High prevalence of bone disease in patients referred for pulmonary rehabilitation

There is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California.

"While post-menopausal women are routinely screened for osteoporosis, men are not," said Kathleen Ellstrom, PhD, RN, APRN-BC, Pulmonary Clinical Nurse Specialist and Director of the Pulmonary Rehabilitation Program at the Veterans Administration Loma Linda Healthcare System. "The high prevalence of bone disease we found in male patients referred to our pulmonary rehabilitation program suggests that should also be performed in men with pulmonary disease."

The results will be presented at the ATS 2012 International Conference in San Francisco.

The study included 46 patients, 43 of whom underwent dual-emission X-ray absorptiometry (DXA) screening. The majority (98%) of patients were male. Diagnoses included (COPD, 80%), (IPF, 16%), and asthma (4%).

Of the 43 patients who underwent DXA scanning, 27 (63%) had positive scans. Of these 27 patients, 21 (78%) had osteopenia and 6 (22%) had osteoporosis. The severity of lung disease was also associated with bone disease as those patients with more severe lung disease were more likely to also have bone disease.

"Smoking and the use of steroids to treat exacerbations in patients with lung disease are factors known to be associated with an increased risk of osteopenia/osteoporosis. In addition, recent evidence suggests that COPD itself may be associated with an increased risk secondary to an inflammatory process independent of steroid use," said Dr. Ellstrom.

"Our findings suggest that routine screening for osteopenia/osteoporosis in with pulmonary disease may help reduce the occurrence of fractures in these patients by identifying at-risk individuals that might otherwise not be evaluated and treated."

More information: "High Prevalence Of Osteopenia/Osteoporosis In Patients Referred For Pulmonary Rehabilitation" (Session A107, Sunday, May 20, Room 3010-3012, Moscone Center; Abstract 32409)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola: Five questions about the killer virus

46 minutes ago

The highly contagious Ebola virus, which has killed more than 4,500 people in west Africa since December and has fueled global alarm, is among the most dangerous ever identified.

Ebola fear, monitoring eases for some in Dallas

56 minutes ago

The people closest to Ebola victim Thomas Eric Duncan are trying to resume their lives now that they have come out of a 21-day incubation period without developing symptoms of the disease.

Third UN employee dies from Ebola

1 hour ago

A UN staff member in Sierra Leone has died from Ebola, the third employee from the world organization to succumb to the deadly virus, the UN spokesman said Monday.

Canadian Ebola vaccine sent to WHO for testing

1 hour ago

The first batch of an experimental Ebola vaccine developed by Canadian scientists was sent to Switzerland on Monday for testing by the World Health Organization, officials said.

User comments